Full Text View
Tabular View
No Study Results Posted
Related Studies
Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes (EZE)
This study is currently recruiting participants.
Study NCT00699023.   Last updated on January 28, 2009.
Information provided by Federico II University
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Postprandial Lipemia
Type 2 Diabetes
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
Hyperlipidemias
More general conditions related to this trial
Dyslipidemias
Endocrine System Diseases
Glucose Metabolism Disorders
Lipid Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
ezetimibe tablets
simvastatin tablets
placebo
Additional drug interventions recognized in this trial
Ezetimibe
Simvastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antilipemic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Federico II University


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services